https://www.marketscreener.com/quote/stock/AFFIMED-N-V-17937579/news/Affimed-Announces-Updated-Data-of-AFM13-in-Combination-with-Keytruda-Pembrolizumab-in-Patients-w-26774409/?utm_source=telegram&utm_medium=social&utm_campaign=share